Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury

Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury

Background: Activated platelets release serotonin during acute myocardial infarction (AMI), aggravating myocardial damage and ischemia/reperfusion (I/R) injury. However, serum serotonin and its potential role as a biomarker for myocardial infarction and I/R injury have not been studied so far. Metho...

Full description

Bibliographic Details
Main Authors: Marina Rieder, Rosmarie Laumann, Thilo Witsch, Nancy Schanze, Lukas Heger, Christoph B. Olivier, Constantin von zur Muehlen, Christoph Bode, Ingo Ahrens, Achim Lother, Daniel Duerschmied, Marcus Hortmann
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Applied Sciences
Subjects:
serotonin
STEMI
ischemia/reperfusion injury
Online Access:https://www.mdpi.com/2076-3417/10/18/6379

Internet

https://www.mdpi.com/2076-3417/10/18/6379

Similar Items